Ignite Creation Date:
2025-12-25 @ 5:11 AM
Ignite Modification Date:
2025-12-26 @ 4:17 AM
Study NCT ID:
NCT01202227
Status:
COMPLETED
Last Update Posted:
2021-01-28
First Post:
2010-08-31
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
An Open-Label Long-Term Study Of Pregabalin For The Treatment Of Central Neuropathic Pain
Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-09
Start Date Type:
None
Primary Completion Date:
2012-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-03
Completion Date Type:
ACTUAL
First Submit Date:
2010-08-31
First Submit QC Date:
None
Study First Post Date:
2010-09-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-01-10
Results First Submit QC Date:
None
Results First Post Date:
2013-05-17
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-01-26
Last Update Post Date:
2021-01-28
Last Update Post Date Type:
ACTUAL